Pharmacology for the Future Science, Drug Development and Therapeutics / July1(Sun)-6(Fri),2018 Kyoto International Conference Center Kyoto, Japan

Scientific Program

As of March 16, 2017 - subject to change

Opening Lecture

Tasuku Honjo, M.D., Ph.D.

TBA

Tasuku Honjo, M.D., Ph.D.
Kyoto University, Japan

Plenary Lecture

Shinya Yamanaka, M.D., Ph.D.

Recent Progress in iPS Cell Research and Application

Shinya Yamanaka, M.D., Ph.D.
Kyoto University, Japan

Karl Deisseroth, M.D., Ph.D.

TBA

Karl Deisseroth, M.D., Ph.D.
Stanford University, USA

Nancy J. Brown, M.D.

The Cardiovascular Effects of Peptidase Inhibition

Nancy J. Brown, M.D.
Vanderbilt University Medical Center, USA

Adam Cohen, M.D., Ph.D.

Drug development as an outcome of integration of basic and clinical pharmacology,

Adam Cohen, M.D., Ph.D.
Center for Human Drug Research, The Netherlands

Tang Prize Lecture

Feng Zhang, Ph.D.

Genome Engineering: Technologies and Applications

Feng Zhang, Ph.D.
McGovern Institute for Brain Research, USA

Analytical Pharmacology Lecture

Bryan L. Roth M.D., Ph.D.

Towards a molecular understanding of drug action at GPCRs

Bryan L. Roth M.D., Ph.D.
Department of Pharmacology, University of North Carolina Chapel Hill School of Medicine, USA

Cutting Edge Lecture

Confirmed Speakers (Presentation themes are tentative.)

Alphabetical order

  1. Lipid mediators: function and therapeutic target for ocular diseases Makoto AiharaDepartment of Ophthalmology, The University of Tokyo, Japan
  2. Structure, Function and Pharmacology of Na+ and Ca2+ Channels at Atomic Resolution William A. CatterallDepartment of Pharmacology, University of Washington, USA
  3. Differential clinical impacts of oxidative stress and nitrosative stress:
    Therapeutic implications
    Samuel H.H. ChanInstitute for Translational Research in Biomedicine, Chang Gung Memorial Hospital, Taiwan
  4. GPCR Allostery and Bias in Modern Pharmacology:
    Structural, pharmacological and clinical implications
    Arthur ChristopoulosMonash Institute of Pharmaceutical Sciences, Monash University, Australia
  5. Neurobiology of Stress, Depression, and Antidepressants:
    Rapid Remodeling of Synaptic Connections
    Ronald S. DumanDepartment of Psychiatry, Yale University School of Medicine, USA
  6. Systems Pharmacology and Translational Therapeutics Garret A. FitzgeraldPerelman School of Medicine, University of Pennsylvania, USA
  7. Drug Discovery for Neglected Diseases Ian GilbertDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK
  8. Future of Pharmacometrics Joga GobburuProfessor of Pharmacy Practice and Science Director, Center for Translational Medicine University of Maryland, USA
  9. TBA John A. HartleyUCL Cancer Institute, USA
  10. Molecular imaging for diagnosis and treatment of neurodegenerative disorders at a prodromal stage Makoto HiguchiNational Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan
  11. Cost-effectiveness Analysis for Health Policy Making in Japan Shunya IkedaSchool of Medicine, International University of Health and Welfare, Japan
  12. Positron Emission Tomography of Human Brain can Monitor Neuroinflammation and cAMP Signaling: Applications to Alzheimer's Disease and Depression Robert B. InnisNational Institute of Mental Health, USA
  13. Human pluripotent stem cells in neurological disease modeling and drug discovery Haruhisa InoueCiRA, Kyoto University, Kyoto, Japan
  14. Pharmacokinetic changes across the developmental trajectory Shinya ItoHospital for Sick Children, University of Toronto, Canada
  15. Molecular Mechanism of Type 2 Diabetes: Perspectives from Insulin Receptor and Adiponectin Receptor Actions Takashi KadowakiDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Toyo, Japan
  16. Microbiome and Epigenetic Effects on Xenobiotic Processing Genes Curtis D. KlaassenUniversity of Washington, USA
  17. Future of regulatory science in drug regulation Tatsuya KondoPharmaceuticals and Medical Devices Agency (PMDA), Japan
  18. Therapeutic Validation of Rasna Panchaka, Poly herbal formulation and ksheer pak by ‘Reverse Pharmacology (RP)’ Tool B. Dinesh KumarHOD Drug Toxicology Division, National Institute of Nutrition, India
  19. Biologics versus small molecules in treatment of systemic autoimmune diseases Masataka KuwanaDepartment of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Japan
  20. Unconventional Secretion of Membrane Protein Min Goo LeeYonsei University, College of Medicince, Korea
  21. Prescribing safety assessment: ensuring competency of new doctors to use medicines Simon MaxwellUniversity of Edinburgh, UK
  22. TBA Stephen B. McMahonKing's College London, UK
  23. RANKL-From basic discovery to clinical application Josef PenningerIMBA-Institute of Molecular Biotechnology, Austria
  24. Control of immune responses by regulatory T cells Shimon SakaguchiDepartment of Experimental Immunology, WPI Immunology Frontier Research Center, Osaka University, Japan
  25. Phospholipids metabolism in health and disease Takao ShimizuDepartment of Lipid Signaling, National Center for Global Health and Medicine/University of Tokyo Faculty of Medicine, Japan
  26. The Role of Public Sector Research in the Discovery of Drugs and Vaccines – an Update Ashley J. StevensFocus IP Group, LLC, USA
  27. Rethinking Sodium Metabolism Jens M. TitzeDivision of Clinical Pharmacology, Vanderbilt University Medical Center, USA
  28. Structural biology of P-type ATPases Chikashi ToyoshimaInstitute of Molecular and Cellular Biosciences, The University of Tokyo, Japan
  29. NSAID-induced gastrointestinal (GI) damage and the design of GI-sparing NSAIDs John L. WallaceDepartment of Physiology & Pharmacology, University of Calgary, Canada
  30. Brain-imaging for the treatment of psychiatric diseases Shigeto YamawakiDepartment of Psychiatry and Neurosciences, Hiroshima University/ Center of Innovation(COI), Japan
  31. TBA Baofeng YangDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, China
  32. Pharmacological Action and Mechanism of Traditional Chinese Medicine Yongxiang ZhangBeijing Institute of Pharmacology and Toxicology, China
Plus
80 Symposia / Workshops
Oral Sessions / Poster Sessions
Luncheon Seminars

Program at a Glance

AM PM
July 1 - Opening Ceremony
Opening Lecture
Welcome Reception
July 2 Plenary Lecture
Cutting Edge Lectures
Symposia / Workshops
Symposia/Workshops
Poster Sessions
Luncheon Seminars
July 3 Plenary Lecture
Cutting Edge Lectures
Symposia/Workshops
Tang Prize Lecture
Symposia/Workshops
Oral Sessions
Poster Sessions
Luncheon Seminars
July 4 Plenary Lecture
Cutting Edge Lectures
Symposia/Workshops
Analytical Pharmacology Lecture
Symposia/Workshops
Oral Sessions
Poster Sessions
Luncheon Seminars
July 5 Plenary Lecture
Symposia/Workshops
Oral Sessions
Poster Sessions
Luncheon Seminars
Gala Dinner (Ticketed Event)
July 6 Cutting Edge Lectures
Symposia/Workshops
Closing Ceremony
-

Congress Secretariat

c/o Congress Corporation
Kohsai-kaikan Bldg., 5-1 Kojimachi,
Chiyoda-ku, Tokyo 102-8481, Japan
TEL: +81-3-5216-5318
FAX: +81-3-5216-5552
E-mail: wcp2018@congre.co.jp